Invirsa, Inc.
🇺🇸 Columbus, Ohio, USAPharmaceuticals
Total raised
$9 M
2 rounds on record
Latest round
$3 M
Jul 2025
First round on record
Dec 2022
Today
Private
No later event on record
Funding rounds
2 counted as startup funding. Open the number of investors for the round's details.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Invirsa, Inc. chose not to state its revenue in its newest notice of a funding round (Aug 2025).
SEC Form D · Aug 2025
The industry group it chose in its notices: Pharmaceuticals.
SEC Form D · Aug 2025
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Invirsa, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Rachael Wingo | Executive officer | Aug 2025 |
| Robert Shalwitz | Executive officer | Aug 2025 |
| Faith Voinovich | Director | Aug 2025 |
| Robert Shalwitz | Director | Aug 2025 |
| Tim Willis | Director | Aug 2025 |
| Wayne Embree | Director | Aug 2025 |
| Samuel Lee | Director | Dec 2022 |